Requirement for Innate Immunity and CD90(+) NK1.1(−) Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy

We sought to define cellular immune mechanisms of synergy between tumor-antigen–targeted monoclonal antibodies and chemotherapy. Established B16 melanoma in mice was treated with cytotoxic doses of cyclophosphamide in combination with an antibody targeting tyrosinase-related protein 1 (αTRP1), a nat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Immunol Res
Hlavní autoři: Moskalenko, Marina, Pan, Michael, Fu, Yichun, de Moll, Ellen H., Hashimoto, Daigo, Mortha, Arthur, Leboeuf, Marylene, Jayaraman, Padmini, Bernardo, Sebastian, Sikora, Andrew G., Wolchok, Jedd, Bhardwaj, Nina, Merad, Miriam, Saenger, Yvonne
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690202/
https://ncbi.nlm.nih.gov/pubmed/25600438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0120
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky